Articles

  • 3 weeks ago | psychiatrictimes.com | Grace Koennecke

    Preliminary findings from the RESTORE-LIFE study (NCT03320304) show long-term effectiveness of vagus nerve stimulation (VN) in patients with difficult-to-treat depression (DTD). The global, prospective, multi-center, observational study is assessing the long-term effectiveness and safety of VNS as an alternative treatment in patients with DTD.

  • 3 weeks ago | psychiatrictimes.com | Grace Koennecke

    MindMed recently announced that the first patient has been dosed in its phase 3 Emerge study evaluating MM120 ODT for treatment of major depressive disorder (MDD). MM120 ODT is a proprietary, pharmaceutically optimized form of lysergic acid diethylamide (LSD). MindMed will also test the efficacy and safety of MM120 ODT 100 µg compared with a placebo, with an expected enrollment of approximately 140 participants in the United States.

  • 1 month ago | psychiatrictimes.com | Grace Koennecke

    Findings from a recent online research study by The Harris Poll indicated that clinicians are concerned about their patients’ quality of life as well as medications issues like adherence and switching.

  • 1 month ago | optometrytimes.com | Grace Koennecke

    Eyenovia recently announced its entrance into a non-binding letter of intent debating a potential reverse merger transaction with Betaliq, a clinical stage pharmaceutical company with a therapeutic focus on glaucoma. The potential merger would create a new ophthalmic company that pairs two FDA-approved technologies – Betaliq’s EyeSOl water-free drug delivery technology for use in glaucoma and Eyenovia’s Optejet topical ophthalmic liquid dispensing platform.

  • 1 month ago | ophthalmologytimes.com | Grace Koennecke

    ZEISS Medical Technology announced the availability of its ZEISS VISULAS Combi, an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution, in Canada. The treatment is designed for retina, cataract, and glaucoma conditions, streamlining workflow with custom modules, a uniform interface, and space-saving features.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
186
Tweets
1K
DMs Open
No
grace koennecke
grace koennecke @grace_koe3
20 Apr 25

https://t.co/dctf0Pghn6

grace koennecke
grace koennecke @grace_koe3
11 Apr 25

https://t.co/4r0kpvwMFM

grace koennecke
grace koennecke @grace_koe3
9 Apr 25

Today, I was so excited to present my senior thesis through the Honors Tutorial College at Ohio University, titled "Exploring the Last 25 Years of Hip-Hop and its Implications." https://t.co/tWjoCq1Fnl